The objective was to study the effects of ethanol on coagulation and fibrinolysis in whole blood. Blood samples from healthy volunteers were analyzed before and after invitro addition of ethanol in order to achieve ethanol concentrations of 0, 1, 2 and 4ø, respectively (0, 22, 44 and 88 mmol/l). Coagulation and fibrinolysis were then assessed using rotational thromboelastometry. We found that increasing ethanol levels increasingly impaired coagulation as evaluated with rotational thromboelastometry, with a maximum prolongation of the clot formation time of 118% at an ethanol level of 4ø (P < 0.000001). We also found a very strong impairment of fibrinolysis already at an ethanol level of 1ø. This is the first study assessing the effects of ethanol on coagulation and fibrinolysis in a whole blood model. The impairment of coagulation is similar in nature to the impairment found in patients suffering from hypothermia. The impairment is at a level that may be of clinical importance (e.g. in patients suffering from trauma). The inhibition of fibrinolysis is obvious already at an ethanol level of 1ø and it may be a contributing factor to the increased amount of coronary and cerebrovascular ischemic events after binge drinking. Blood Coagul Fibrinolysis 17:661-665 ß 2006 Lippincott Williams & Wilkins. Blood Coagulation and Fibrinolysis 2006, 17:661-665 
Introduction
The use and abuse of alcoholic beverages are common features in trauma patients [1, 2] . More than 30% of injured drivers admitted to a trauma center have detectable alcohol levels in their blood [3] .
It is in our clinical experience common that patients suffering from traumatic brain injuries (TBI) have pronounced progression of their intracranial hemorrhages (e.g. contusions). It is also known that impairment of the coagulation of different origins (e.g. nonsteroidal antiinflammatory drug treatment or consumption coagulopathy) is associated with worse outcome in TBI patients [4] [5] [6] .
In our clinical experience it is also common that patients with high ethanol levels suffering from TBI have pronounced progression of their intracranial hemorrhagic complications. Effects on the coagulation and fibrinolytic systems by increased ethanol levels have been previously described. These studies, however, have in general been performed on components of blood, rather than on whole blood, and the effects reported are not in agreement. Several studies have found an alcohol-induced impairment of the primary hemostasis, whereas the humoral coagulation factors and the fibrinolytic system were unaffected [7] [8] [9] . El-Sayed et al. [10] corroborated these results on the humoral coagulation factors and the fibrino-lysis, but other workers have found an acute impairment of the fibrinolytic system by increased ethanol levels [11, 12] . One study also described an increase in fibrinolytic activity after alcohol withdrawal in chronic alcoholics [13] . Another study found somewhat contrasting results indicating an increase in platelet aggregation after binge drinking [14] .
These observations have led us to perform a study where we have evaluated the effects of increased blood ethanol levels on the hemostatic and fibrinolytic systems. We have used rotational thromboelastometry (ROTEM) to perform the studies. ROTEM is a whole blood method assessing both hemostasis (humoral coagulation and platelet activity) and fibrinolysis in the same analysis. ROTEM is considered a better predictor of clinical bleeding tendency than other coagulation tests [15] [16] [17] .
Materials and methods
The study was approved by the ethics committee of Lund University Hospital, Sweden. Six healthy volunteers gave informed consent to participate in the study.
Blood sampling
An indwelling brachial venous catheter was used for blood sampling. Four blood samples were taken from each participant. Each blood sample consisted of 4 ml blood collected in a siliconated test tube without additives. The initial blood drawn before each sampling was discarded. One blood sample was analyzed without addition of any ethanol. The other three samples were analyzed after addition of 5, 10 and 20 ml of 96% pure ethanol, resulting in ethanol concentrations of 1, 2 and 4%, respectively.
Thromboelastometry
A ROTEM analyzer (Pentapharm GMBH, Munich, Germany) was used. All analyses were performed at 378C and the analyses were performed on whole blood. Coagulation was activated with 20 ml tissue factor containing activator according to the EXTEG procedure described by the manufacturer. Four parameters were measured. The first parameter was the clotting time, measuring the time to initiation of clot formation and reflecting the initiation of the coagulation. The clot formation time (CFT), measuring the rate of increasing clot firmness once the clotting has started, reflecting platelet activity and the rate of fibrinogen to fibrin conversion, was also measured. The maximum clot firmness (MCF), describing the maximum strength of the clot, is another parameter measured that is primarily affected by the platelet count. The lysis index after 60 min (LI 60 ), describing the fibrinolytic activity as the clot firmness 60 min after initiation of the analysis as a percentage of the MCF, was the final parameter measured ( Fig. 1) .
Analyses
Blood was mixed with ethanol immediately after the blood was drawn. ROTEM analysis was started exactly 90 s after the blood was drawn by adding 320 ml blood to a cuvette already containing 20 ml of tissue factor containing activator according to the standard ROTEM procedure.
Statistical analysis
Box plots show medians with the box representing the 25th-75th percentiles and the whiskers representing the range. All statistical analyses were performed with non-parametric statistical methods. The Wilcoxon rank order test was used to study the effects on fibrinolysis.
The Spearman rank order test was used for correlation analysis of the effects on the coagulation system. A P value less than 0.05 was considered statistically significant.
Results
No participant withdrew from the study and the blood sampling was performed uneventfully. Increasing ethanol concentrations progressively impaired the coagulation system. The impairment was seen in the CFT (P < 0.000001, r ¼ 0.91) and the a-angle (P ¼ 0.000001, r ¼ 0.88) (Fig. 2) . The CFT was prolonged by 34% at an ethanol level of 1% and by 118% at an ethanol level of 4%. There were no significant changes to the clotting time and the MCF.
The fibrinolysis was also significantly impaired with a virtually total elimination of fibrinolytic activity (P ¼ 0.03) already at an ethanol level of 1%. The median LI 60 value was 90% when there was no ethanol added to the blood (Fig. 3a) . At an ethanol level of 1% the median LI 60 value was 97% (Fig. 3b) . At higher ethanol levels, the LI 60 value was 98%.
Discussion
ROTEM is gaining increasing popularity as a coagulation monitoring tool as the technique becomes more userfriendly and robust. It seems to be more sensitive and specific than routine coagulation tests in detecting defects of the coagulation system [16, [18] [19] [20] [21] [22] .
It has also been used as a tool for detection of coagulation defects in patients undergoing cardiac and liver surgery [15, [23] [24] [25] [26] . ROTEM measures the rate of clot formation and clot strengthening. The result is displayed as a graph where the clot strength is found on the y axis and the time is displayed on the x axis ( Fig. 1 ).
In this study we have found that increased ethanol levels correlated to an impairment of the in-vitro coagulation. The impairment was seen as a prolongation of CFT and a lowering of the a-angle. These parameters primarily Ethanol impairs the coagulation system Engströ m et al. 663 reflect the fibrinogen to fibrin conversion and the platelet activity, even though all parameters in some way are a reflection of thrombin generation, which in turn leads to clot formation and stabilization. There were no changes in the initiation phase or in the maximum strength of the clot. These findings may indicate that the reactions are still running, but at a lower rate. The coagulation would then be initiated at the correct time but run slower, and the clot strength would eventually reach the same strength but at a later point in time, explaining the absence of any change in the clotting time and the MCF.
Previous studies investigating the effects of acidosis and of hypothermia on the coagulation system have found impairments of the coagulation very similar in nature to the effects of increased ethanol levels [27, 28] . The effects are readily detectable already at an ethanol level of 1% and may be of importance in trauma patients. The link between impairment of the coagulation system and progression of intracranial hemorrhage in trauma patients has been well described [29, 30] . A link between impairment of coagulation and worse outcome has also been found [5, 6] . The finding that thrombocytopenia at admission predicts progressive hemorrhage in TBI patients indicates a correlation between the coagulation system and progressive hemorrhage [31] . Altogether, many TBI patients have multiple reasons for developing delayed hemorrhagic complications, and the ethanol level may be another factor necessary to consider during management of TBI patients. Ethanol has been found to decrease collagen-induced platelet aggregation and this may be a problem viewed in the light of the finding that patients on non-steroidal anti-inflammatory drugs have a higher mortality rate after TBI [4, 32] . In our study we also found a prolongation of the CFT that may be interpreted as an impairment of the platelet activity.
Another aspect of the effects of ethanol on coagulation is the impairment of fibrinolysis. An impairment has been described previously, but not in whole blood. Several different studies have addressed this issue and found somewhat conflicting results. Most studies have found an increase in fibrinolytic activity after ethanol intake. Some studies have found an upregulation of tissue-type plasminogen activator expression and a decrease in plasminogen activator inhibitor-1 transcription, something that would explain the increased fibrinolytic activity [33] [34] [35] [36] . There are also studies, however, that have found an acute inhibitory effect or no effect at all of ethanol on fibrinolysis [9] [10] [11] . We found a decrease in fibrinolytic activity in this study; a finding supporting van de Wiel et al., who found similar results in their study [11] . A weakness in our study, however, is that we are not able to detect interactions between the endothelium and components in blood that may be of importance in this process.
A possible explanation of the conflicting results regarding the effects of ethanol on fibrinolysis may be that ethanol acutely impairs fibrinolysis, but upregulates transcription of profibrinolytic genes (e.g. tissue-type plasminogen activator genes) and downregulates antifibrinolytic genes (e.g. plasminogen activator inibitor-1), leading to an increase in fibrinolytic activity in the longer perspective. This would also explain the increased risk for ischemic coronary or cerebrovascular disease after binge drinking, even though a moderate intake of ethanol in the longer perspective may be protective against such diseases.
In conclusion, ethanol impairs the coagulation system and seems to inhibit fibrinolysis in the short perspective. Intoxication by ethanol may be a risk factor for increased hemorrhage in patients suffering from trauma.
